INSIGHTS ON DRUG DEVELOPMENT
-
Column Selection For RPLC-UV Impurity Analysis
Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.
-
Solutions For CQA Analysis Of IVT mRNA-Based Biotherapeutics
Discover new innovative solutions for mRNA analysis, enhancing accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.
-
Optimize Your RNA-LNP Delivery With Ionizable Lipids
Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.
-
Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up
SDD scale-up introduces scale-dependent risks that threaten bioavailability, stability, and manufacturability. This white paper details a model-based framework for managing those risks from early feasibility through commercial production.
-
Temperature Dependence On Reversed-Phase Separations7/17/2025
Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.
-
Three Keys To E&L Success: Study Design, Partner Selection, And Timing7/16/2026
Successful E&L planning starts before testing begins. Aligning study design, partner expertise, and timing helps teams focus on the right risks, avoid surprises, and support stronger development.
-
Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development3/3/2026
Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.
-
Microflow Columns Boost GLP-1 Sensitivity And Reduce Solvent5/7/2026
Microflow chromatography offers a practical way to boost GLP‑1 assay sensitivity while cutting solvent use. See how 1.0 mm columns improve peak response without sacrificing chromatographic performance.
-
IP Considerations In Drug Development For Biotech Companies4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.
DRUG DEVELOPMENT SOLUTIONS
-
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
Emulate's kits provide the essential components needed to create functional, living organ models on the Zoë® Culture Module.
-
Access all the service, support, and performance maintenance options you need for uninterrupted performance – giving your lab more control over your service, maintenance costs, and enabling you to optimize your laboratory productivity.
-
Discover an automated solution that revolutionizes 3D model creation for life scientists to enhance throughput and precision integrated with advanced imaging and analysis systems.
-
Leica DM300
For slightly more advanced students in biology or 2-4 year college life science classrooms, the Leica DM300 compound microscope is compact, maintenance-free and easy to use to provide trouble free operation each day.
Equipped with a mechanical stage to accommodate two specimen slides and labelled Abbe condenser, the DM300 can be configured with rotatable monocular or binocular tubes for shared viewing and easy storage. Trinocular tube is also possible to go digital.
With 165 years of microscope design and manufacturing experience, the Leica DM300 student microscope provides students with the capabilities they need to study the finest details in all the Life Sciences.